Doxorubicin Hydrochloride is a widely used clinical chemotherapeutic drug belonging to the anthracycline antibiotic class, which exerts its anti-tumor effect by interfering with DNA replication and transcription in cancer cells. It is used to treat a variety of solid tumors and hematologic malignancies, including breast cancer, lung cancer, leukemia, and lymphoma. Once in the body, Doxorubicin Hydrochloride rapidly enters the cell nucleus, forming complexes with DNA to inhibit nucleic acid synthesis and induce apoptosis, effectively suppressing tumor cell proliferation. The drug is typically administered via intravenous injection, with careful dosage and scheduling required to minimize cardiotoxicity and other systemic side effects. Doxorubicin Hydrochloride offers high anti-cancer activity and controllable safety, making it an essential medication in modern chemotherapy regimens, providing effective treatment options for patients and playing a key role in managing various types of cancers.

2026-02-10Report Format： Single user version：3500.00 USD

Doxorubicin Hydrochloride is a widely used clinical chemotherapeutic drug belonging to the anthracycline antibiotic class, which exerts its anti-tumor effect by interfering with DNA replication and transcription in cancer cells. It is used to treat a variety of solid tumors and hematologic malignancies, including breast cancer, lung cancer, leukemia, and lymphoma. Once in the body, Doxorubicin Hydrochloride rapidly enters the cell nucleus, forming complexes with DNA to inhibit nucleic acid synthesis and induce apoptosis, effectively suppressing tumor cell proliferation. The drug is typically administered via intravenous injection, with careful dosage and scheduling required to minimize cardiotoxicity and other systemic side effects. Doxorubicin Hydrochloride offers high anti-cancer activity and controllable safety, making it an essential medication in modern chemotherapy regimens, providing effective treatment options for patients and playing a key role in managing various types of cancers.

2026-02-10Report Format： Single user version：2800.00 USD

Hydrotalcite Chewable Tablets are over-the-counter oral medications designed to relieve excessive stomach acid, indigestion, and gastrointestinal discomfort, widely used for daily digestive health. Upon chewing, the active ingredients are quickly released in the mouth, neutralizing stomach acid and effectively alleviating heartburn, acid reflux, and related symptoms while protecting the gastric mucosa. These chewable tablets have a pleasant taste, are easy to take, and suitable for both adults and children, providing convenient relief anytime, anywhere. Manufactured according to strict pharmaceutical standards, they are safe, free from harmful substances, and offer consistent effects. With their efficiency, safety, and convenience, Hydrotalcite Chewable Tablets play an important role in gastrointestinal health and digestive comfort, making them an essential healthcare product for daily family and personal use.

2026-02-10Report Format： Single user version：3500.00 USD

Hydrotalcite Chewable Tablets are over-the-counter oral medications designed to relieve excessive stomach acid, indigestion, and gastrointestinal discomfort, widely used for daily digestive health. Upon chewing, the active ingredients are quickly released in the mouth, neutralizing stomach acid and effectively alleviating heartburn, acid reflux, and related symptoms while protecting the gastric mucosa. These chewable tablets have a pleasant taste, are easy to take, and suitable for both adults and children, providing convenient relief anytime, anywhere. Manufactured according to strict pharmaceutical standards, they are safe, free from harmful substances, and offer consistent effects. With their efficiency, safety, and convenience, Hydrotalcite Chewable Tablets play an important role in gastrointestinal health and digestive comfort, making them an essential healthcare product for daily family and personal use.

2026-02-10Report Format： Single user version：2800.00 USD

Muscle Pain Relief Cream is a topical care product specifically designed to alleviate muscle soreness, stiffness, and fatigue, suitable for post-exercise recovery, daily strain, or chronic muscle discomfort. Combining natural active ingredients with a scientifically developed formula, the cream gently penetrates the skin to reach the muscle tissue, improving local blood circulation and relieving tension and pain. It is easy to apply, absorbs quickly without leaving a greasy residue, and its effects can be further enhanced with gentle massage. The cream offers anti-inflammatory, pain-relieving, and muscle-relaxing benefits, effectively supporting recovery after physical activity, enhancing comfort after long work periods, and managing chronic discomfort. Highly safe for long-term use, it is non-irritating, odor-free, and compatible with standard care routines. With its efficiency, safety, and convenience, Muscle Pain Relief Cream provides a reliable solution for muscle care, helping users restore vitality and comfort after exercise or daily exertion.

2026-02-10Report Format： Single user version：3500.00 USD

Muscle Pain Relief Cream is a topical care product specifically designed to alleviate muscle soreness, stiffness, and fatigue, suitable for post-exercise recovery, daily strain, or chronic muscle discomfort. Combining natural active ingredients with a scientifically developed formula, the cream gently penetrates the skin to reach the muscle tissue, improving local blood circulation and relieving tension and pain. It is easy to apply, absorbs quickly without leaving a greasy residue, and its effects can be further enhanced with gentle massage. The cream offers anti-inflammatory, pain-relieving, and muscle-relaxing benefits, effectively supporting recovery after physical activity, enhancing comfort after long work periods, and managing chronic discomfort. Highly safe for long-term use, it is non-irritating, odor-free, and compatible with standard care routines. With its efficiency, safety, and convenience, Muscle Pain Relief Cream provides a reliable solution for muscle care, helping users restore vitality and comfort after exercise or daily exertion.

2026-02-10Report Format： Single user version：2800.00 USD

Nectin-4 ADC drugs are a class of innovative anticancer therapies that target Nectin-4 and are mainly used for the precise treatment of various malignant tumors. These drugs utilize specific antibodies to recognize and bind to Nectin-4, which is highly expressed on the surface of tumor cells, and deliver potent cytotoxic agents directly into cancer cells. This targeted delivery significantly enhances antitumor efficacy while minimizing damage to normal tissues. Nectin-4 is highly expressed in several solid tumors, including urothelial carcinoma and breast cancer, making it an ideal therapeutic target. Compared with conventional chemotherapy, Nectin-4 ADC drugs offer stronger targeting ability, relatively lower toxicity, and a wider therapeutic window. With continuous advancements in biopharmaceutical technologies and conjugation processes, these drugs show great potential in improving patient survival rates and quality of life, and have become an important development direction in the field of precision oncology.

2026-02-10Report Format： Single user version：3500.00 USD

Nectin-4 ADC drugs are a class of innovative anticancer therapies that target Nectin-4 and are mainly used for the precise treatment of various malignant tumors. These drugs utilize specific antibodies to recognize and bind to Nectin-4, which is highly expressed on the surface of tumor cells, and deliver potent cytotoxic agents directly into cancer cells. This targeted delivery significantly enhances antitumor efficacy while minimizing damage to normal tissues. Nectin-4 is highly expressed in several solid tumors, including urothelial carcinoma and breast cancer, making it an ideal therapeutic target. Compared with conventional chemotherapy, Nectin-4 ADC drugs offer stronger targeting ability, relatively lower toxicity, and a wider therapeutic window. With continuous advancements in biopharmaceutical technologies and conjugation processes, these drugs show great potential in improving patient survival rates and quality of life, and have become an important development direction in the field of precision oncology.

2026-02-10Report Format： Single user version：2800.00 USD

HER2 ADC drugs for cancer are a class of antibody–drug conjugates that target human epidermal growth factor receptor 2 and are used for the precise treatment of various HER2-positive tumors. These drugs employ highly specific monoclonal antibodies to recognize and bind to HER2, which is overexpressed on the surface of cancer cells, delivering potent cytotoxic payloads directly into tumor cells. This targeted approach enhances antitumor efficacy while minimizing damage to normal tissues. HER2 plays a critical role in multiple malignancies, including breast cancer, gastric cancer, and lung cancer, making it a well-established and clinically validated therapeutic target. Compared with conventional chemotherapy and single-agent targeted therapies, HER2 ADC drugs offer stronger targeting capability, improved therapeutic outcomes, and better safety profiles. With continuous advancements in conjugation technologies and payload optimization, HER2 ADC drugs show significant potential in prolonging patient survival and improving quality of life, and have become an important component of precision oncology.

2026-02-10Report Format： Single user version：3500.00 USD

HER2 ADC drugs for cancer are a class of antibody–drug conjugates that target human epidermal growth factor receptor 2 and are used for the precise treatment of various HER2-positive tumors. These drugs employ highly specific monoclonal antibodies to recognize and bind to HER2, which is overexpressed on the surface of cancer cells, delivering potent cytotoxic payloads directly into tumor cells. This targeted approach enhances antitumor efficacy while minimizing damage to normal tissues. HER2 plays a critical role in multiple malignancies, including breast cancer, gastric cancer, and lung cancer, making it a well-established and clinically validated therapeutic target. Compared with conventional chemotherapy and single-agent targeted therapies, HER2 ADC drugs offer stronger targeting capability, improved therapeutic outcomes, and better safety profiles. With continuous advancements in conjugation technologies and payload optimization, HER2 ADC drugs show significant potential in prolonging patient survival and improving quality of life, and have become an important component of precision oncology.

2026-02-10Report Format： Single user version：2800.00 USD